TCT-32 First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions
2013 ◽
Vol 62
(18)
◽
pp. B11
◽
2018 ◽
Vol 72
(13)
◽
pp. B128-B129
2019 ◽
Vol 74
(13)
◽
pp. B164
2013 ◽
Vol 61
(10)
◽
pp. E1731
◽
2012 ◽
Vol 60
(17)
◽
pp. B11
◽
2012 ◽
Vol 59
(13)
◽
pp. E319
◽
2014 ◽
Vol 63
(12)
◽
pp. A1706
◽
2017 ◽
Vol 69
(16)
◽
pp. S2